Corneal dystrophies are a group of inherited eye conditions in which abnormal material slowly builds up in one or more layers of the cornea, the clear front window of the eye. Most are caused by a single gene mutation passed from parent to child, they tend to affect both eyes, and they progress gradually over years or decades. There are more than twenty recognized forms, ranging from types so mild that many people never notice them to types that cloud vision enough to require a corneal transplant.
How Corneal Dystrophies Are Classified
The cornea has five distinct layers, stacked from front to back: the epithelium, Bowman layer, stroma, Descemet membrane, and endothelium. Corneal dystrophies are named and grouped by which layer is most affected. A dystrophy that primarily disrupts the outermost epithelial layer behaves very differently from one that damages the innermost endothelial cells, even though both fall under the same umbrella term.
The international standard for sorting them out is the IC3D classification, maintained by a committee of corneal specialists. It catalogues each dystrophy in a standardized template that includes genetic, clinical, and pathological information, and assigns each one a category number from 1 (strongest evidence that it is a distinct dystrophy) to 4 (weakest evidence).1PubMed Central. The IC3D Classification of the Corneal Dystrophies The most recent edition, published in 2024, updated all 22 templates and reclassified several dystrophies on the basis of new genetic and clinical data.2PubMed Central. IC3D Classification of Corneal Dystrophies-Edition 3 For the practical purposes of understanding what you or a family member might be dealing with, the layer-by-layer breakdown is the most useful framework.
Genetics and Inheritance Patterns
Nearly all corneal dystrophies are genetic. They can follow an autosomal dominant pattern (one copy of the mutated gene from one parent is enough to cause the condition), an autosomal recessive pattern (you need a copy from each parent), or, rarely, an X-linked recessive pattern.3PubMed Central. Corneal dystrophies In practice, the most common forms are autosomal dominant, which means if one of your parents has the condition, there is roughly a one-in-two chance it was passed on to you.
One gene in particular, TGFBI on chromosome 5, deserves special mention because mutations in it cause several of the best-known stromal dystrophies, including granular corneal dystrophy and most types of lattice corneal dystrophy. More than 30 mutations have been identified in TGFBI so far, with two hotspot positions (arginine residues at positions 124 and 555) accounting for the majority of cases across different populations. A mutation at one hotspot produces a specific type of lattice or granular dystrophy, while a mutation at the other produces a different type.4PubMed. TGFBI gene mutations in corneal dystrophies Because so many dystrophies trace back to this single gene, genetic testing can often confirm a diagnosis and help predict the likely course of the disease.
For families with a known corneal dystrophy, genetic testing can do more than identify what type is present. It can guide genetic counseling for future pregnancies, provide an accurate prognosis, and in some cases make a child eligible for gene-specific therapeutic trials.5Springer Link / PubMed Central. Genetic Testing in Pediatric Ophthalmology
Epithelial and Bowman Layer Dystrophies
These affect the cornea’s outermost layers and are among the most common types overall. The one you are most likely to encounter is epithelial basement membrane dystrophy (EBMD), sometimes called map-dot-fingerprint dystrophy because of the characteristic patterns an eye doctor can see on the corneal surface. EBMD produces abnormalities at the junction where the epithelium attaches to the layer below it. In a study of patients with EBMD, over 80 percent had a history of recurrent corneal erosions, episodes where the surface layer peels away and exposes the nerve-rich tissue underneath.6PubMed. Epithelial basement membrane dystrophy: evaluation with the HRT II Rostock Cornea Module These erosions are extremely painful and tend to strike when you first open your eyes in the morning, because the eyelid can stick to the loosely attached epithelium overnight and then rip it off.
Meesmann corneal dystrophy is a rarer epithelial form that typically shows up in childhood. It is caused by mutations in the keratin 3 or keratin 12 genes, which encode structural proteins specific to the corneal epithelium. Tiny fluid-filled microcysts form within the epithelial layer, making the cornea fragile.7PubMed Central. Genetics of Meesmann corneal dystrophy: a novel mutation in the keratin 3 gene in an asymptomatic family suggests genotype-phenotype correlation In many families, Meesmann produces only mild symptoms or none at all, and some carriers go undiagnosed for life.
Stromal Dystrophies
The stroma makes up about 90 percent of the cornea’s thickness, so dystrophies in this layer can have a large impact on clarity. The TGFBI-related dystrophies mentioned earlier, granular and lattice, are the headline examples. In granular dystrophy, the deposits look like small white crumbs scattered through the stroma; in lattice dystrophy, the deposits form branching, refractile lines. Both types are dominantly inherited, progressive, and tend to cloud vision more with each passing decade.
Macular corneal dystrophy stands apart from the group in several ways. It is autosomal recessive rather than dominant, caused by mutations in the CHST6 gene rather than TGFBI. The mutation leads to abnormal proteoglycan synthesis, and the resulting deposits of unsulfated keratan sulfate proteoglycans accumulate in both the stroma and the endothelium.8PubMed. Macular Corneal Dystrophy: An Updated Review9Medicine in Drug Discovery. Roles of matrix metalloproteinases in the cornea: A special focus on macular corneal dystrophy – Section: Macular corneal dystrophy: mechanism of deposit formation and roles of collagenases Macular dystrophy also tends to cause more severe and earlier vision loss than granular or lattice dystrophy, and it can develop in childhood.
A less common but distinctive stromal dystrophy is Schnyder corneal dystrophy, in which cholesterol crystals accumulate in the cornea, giving it a shiny, crystalline haze. This one is caused by mutations in the UBIAD1 gene. Research in mice carrying one of these mutations has shown that the faulty protein prevents the normal breakdown of an enzyme involved in cholesterol production, causing cholesterol to build up in the cornea over time.10PLOS Genetics. Schnyder corneal dystrophy-associated UBIAD1 mutations cause corneal cholesterol accumulation by stabilizing HMG-CoA reductase People with Schnyder dystrophy sometimes also have elevated blood cholesterol, so a lipid panel can be worth checking.
Endothelial Dystrophies
The endothelium is a single-cell-thick layer at the back of the cornea whose job is to pump fluid out and keep the stroma from swelling. Unlike most of the body’s cells, corneal endothelial cells do not regenerate well in adults, so once they are lost, they are gone. Endothelial dystrophies are clinically significant because progressive cell loss eventually leads to corneal swelling and clouding that cannot correct itself.
Fuchs endothelial corneal dystrophy (FECD) is the most common endothelial form and one of the leading reasons people need corneal transplants worldwide. It involves the formation of tiny bumps called guttae on Descemet membrane and a gradual decline in endothelial cell density. A strong genetic component is linked to a trinucleotide repeat expansion in the TCF4 gene. In a recent mouse model carrying 100 copies of this repeat, animals developed progressive guttae and significantly reduced endothelial cell density compared to controls.11PubMed Central. Generation of a Mouse Model of Fuchs Endothelial Corneal Dystrophy by Knock-in of CTG Trinucleotide Repeat Expansion in the TCF4 Gene FECD is unusual among corneal dystrophies in that it often does not become symptomatic until middle age or later, and it affects women more frequently than men.
Posterior polymorphous corneal dystrophy (PPCD) is a rarer endothelial condition with a very different mechanism. In PPCD, the endothelial cells take on an abnormal shape and behavior, growing in multiple layers and expressing characteristics normally seen only in epithelial cells. Mutations in the TCF8 gene (also known as ZEB1) have been identified in some families.12PubMed Central. Mutations in TCF8 cause posterior polymorphous corneal dystrophy and ectopic expression of COL4A3 by corneal endothelial cells The overgrown endothelial cells can spread across the trabecular meshwork, the drain at the angle where the iris meets the cornea, and produce an abnormal basement membrane. All patients with broad-based adhesions between the iris and cornea in PPCD have elevated eye pressure, and some develop elevated pressure even without visible adhesions.13PubMed Central. Posterior polymorphous corneal dystrophy: a disease characterized by epithelial-like endothelial cells which influence management and prognosis This makes glaucoma monitoring an essential part of managing PPCD, even when the cornea itself looks relatively clear.
What Symptoms Feel Like Day to Day
Symptoms vary hugely depending on the type and stage. Many people with early epithelial or stromal dystrophies notice nothing at all for years. When symptoms do appear, the most common are blurred vision, glare or halos around lights, and a sense that the eyes are “foggy,” especially in the morning. The morning fog is particularly characteristic of Fuchs dystrophy, because the endothelial pump works less efficiently during sleep when the eyes are closed and no evaporation is occurring; the cornea retains fluid overnight and slowly clears as the day goes on.
Recurrent erosions, the hallmark of epithelial dystrophies like EBMD, cause sudden sharp pain, tearing, and light sensitivity. They can be debilitating even when the erosion is tiny, because the cornea is one of the most densely nerve-packed tissues in the body. In Fuchs dystrophy specifically, research has shown that when the cornea swells, light scatter from the front surface increases substantially, and eyes with advanced disease recover from that scatter more slowly than healthy eyes.14PubMed Central. Corneal optical changes associated with induced edema in Fuchs endothelial corneal dystrophy In practical terms, people with moderate-to-advanced Fuchs dystrophy may find that their vision is significantly worse in the morning and improves by midday, then worsens again if they are tired or in a humid environment.
A prospective case-control study found that patients with corneal dystrophies reported reductions not just in vision-related activities but also in physical health, mental health, social functioning, and independence. The disease affected people in ways that went well beyond how clearly they could see.15PubMed Central. Reduced quality of life in corneal dystrophy – a prospective case control study That broader impact is worth being honest about: losing confidence in your vision affects driving, reading, work, hobbies, and relationships, and the slow progression can make people feel anxious about the future even when their current vision is still functional.
Diagnosis and Imaging
Most corneal dystrophies are first spotted during a routine slit lamp examination, the microscope your eye doctor uses to look at the front of your eye. The patterns of deposits, their depth, and their shape give strong clues to the type. A family history of similar eye problems is often the clinching detail.
For endothelial dystrophies, specular microscopy is the standard tool. It photographs the endothelial cell layer so cells can be counted and measured. In Fuchs dystrophy, three-dimensional anterior segment optical coherence tomography (AS-OCT) has emerged as an additional method for visualizing guttae and corneal swelling, which may help with staging the disease and tracking its progression.16PLoS ONE. Corneal endothelium features in Fuchs’ Endothelial Corneal Dystrophy: A preliminary 3D anterior segment optical coherence tomography study In practice, your doctor will likely use a combination of slit lamp grading, pachymetry (measuring corneal thickness), and specular microscopy to monitor you over time.
Genetic testing is increasingly available and can be useful in ambiguous cases, for confirming a specific subtype, or for guiding family counseling. It is especially valuable in TGFBI-related dystrophies, where the specific mutation predicts whether deposits will be granular, lattice, or mixed, and whether they are likely to recur after surgery.
Non-Surgical Treatment
For mild disease, the goal is managing symptoms and protecting the corneal surface. Recurrent erosions from epithelial dystrophies are treated with lubricating drops and ointments, especially at bedtime, to prevent the eyelid from sticking to the cornea. Some patients wear a bandage contact lens during acute erosion episodes or use hypertonic saline drops (typically 5 percent sodium chloride) to draw fluid out of a swollen cornea.
In Fuchs dystrophy, hypertonic saline drops and directing a hairdryer at the closed eyes in the morning (the warm, dry air helps evaporate excess fluid) are time-honored first-line measures. A case report documented how therapeutic soft contact lenses combined with 5 percent sodium chloride drops reduced corneal thickness, lowered corneal haze, and improved visual acuity in a patient with Fuchs dystrophy.17American Journal of Ophthalmology Case Reports. Therapeutic contact lens for Fuchs endothelial corneal dystrophy: Monitoring with Scheimpflug tomography These measures buy time but do not reverse the underlying endothelial cell loss.
Surgical Options
When vision deteriorates enough to interfere with daily life, surgery becomes the main path forward. The procedure depends on which layer is affected.
For epithelial dystrophies with recurrent erosions that will not settle, phototherapeutic keratectomy (PTK) uses an excimer laser to remove the outermost abnormal tissue. It is also used after deeper surgeries when surface scarring develops. For stromal dystrophies with significant deposits, lamellar keratoplasty (replacing part of the cornea’s thickness) or penetrating keratoplasty (a full-thickness transplant) may be needed.
For endothelial dystrophies, the field has shifted dramatically toward selective endothelial transplants. Descemet membrane endothelial keratoplasty (DMEK) and Descemet stripping automated endothelial keratoplasty (DSAEK) replace only the diseased endothelial layer and Descemet membrane, leaving the rest of the cornea intact. DMEK delivers faster visual recovery than DSAEK, though both can fully restore endothelial function.18PubMed Central. Phototherapeutic keratectomy for anterior stromal fibrosis following DMEK The smaller wound size and faster healing have made DMEK the preferred technique for Fuchs dystrophy at most corneal centers.
Recurrence After Transplant
One of the most frustrating aspects of corneal dystrophies, and one that patients are often not warned about clearly enough, is that stromal dystrophies can come back in the transplanted tissue. The recipient’s cells continue to produce the abnormal protein, and deposits slowly reappear in the graft. In granular dystrophy, recurrence within the graft was nearly universal within four years of surgery.19PubMed. Granular corneal dystrophy. Visual results and pattern of recurrence after lamellar or penetrating keratoplasty
Lattice dystrophy also recurs frequently. In one study, 60 percent of transplanted eyes with lattice dystrophy developed visible recurrence, although only about 17 to 20 percent had clinically significant recurrence (meaning it caused erosions or reduced vision) within five years.20PubMed. Recurrence of corneal stromal dystrophies after penetrating keratoplasty Avellino dystrophy (a combined granular-lattice type) can recur at the host-graft junction or across the full graft surface, particularly in patients who carry two copies of the mutation.21PubMed Central. Corneal electrolysis for recurrence of corneal stromal dystrophy after keratoplasty
Endothelial transplants for Fuchs dystrophy, by contrast, are not expected to recur in the same way, because the transplant replaces the defective endothelial cells with healthy donor cells. The concern in that setting is graft rejection or long-term cell loss from the donor tissue rather than dystrophy recurrence.
Emerging Therapies
The most exciting development in corneal dystrophy treatment is the possibility of skipping transplantation altogether for endothelial diseases. Researchers have cultured healthy corneal endothelial cells in the lab, then injected them directly into the eye along with a ROCK inhibitor (a drug that helps the cells attach and survive on the inner corneal surface). Early results have been striking: sustained corneal clarity and visual restoration lasting five to ten years after a single injection, with no need for donor tissue in the traditional sense.22PubMed Central. Current Landscape and Future Prospects of Corneal Regenerative Medicine This approach is still making its way through larger clinical trials, but if it holds up, it would transform how Fuchs dystrophy and similar conditions are managed.
Beyond cell therapy, other experimental approaches include bioengineered grafts and gene therapy. ROCK inhibitor eye drops alone, without injected cells, have shown some ability to stimulate the remaining endothelial cells and improve corneal clarity in early-stage disease.23PubMed Central. New Horizons in the Treatment of Corneal Endothelial Dysfunction Gene therapy using CRISPR-based approaches is being explored as a way to correct the underlying mutations in inherited dystrophies, though this work is still in its earliest stages. For stromal dystrophies, where recurrence after transplant remains a major problem, gene correction could eventually address the root cause rather than just replacing the clouded tissue.
When Corneal Dystrophy Shows Up in Children
Most corneal dystrophies progress slowly enough that they do not cause trouble until adulthood, but some forms appear in childhood. Macular corneal dystrophy and some variants of lattice dystrophy can produce noticeable clouding before the teenage years. Meesmann dystrophy is present from birth in theory, though it is often so mild that it is picked up incidentally during an eye exam for something else.
For a child with a family history of corneal dystrophy, an early eye examination can establish a baseline. If the specific mutation in the family is known, genetic testing can confirm whether the child is affected, which helps set expectations and plan monitoring. In families with autosomal dominant forms, half of children are expected to carry the mutation. Knowing early does not change the biology, but it removes uncertainty and allows the family to watch for the first signs of progression rather than being caught off guard.
Macular dystrophy deserves extra attention in pediatric settings because it can cause dense central corneal clouding that, if it develops early enough, could interfere with visual development. Children with significant stromal haze may need to be monitored for amblyopia (reduced vision from disuse during the critical developmental period) and managed more aggressively than adults with the same level of clouding.
How LASIK and Refractive Surgery Interact With Corneal Dystrophies
This is a practical point that catches people off guard. LASIK and similar refractive surgeries reshape the corneal stroma with a laser, and performing them on a cornea with an undiagnosed dystrophy can cause serious problems. In the case of TGFBI dystrophies, the surgical wound and healing response can accelerate deposit formation. Several case reports in the literature describe granular or Avellino dystrophy deposits suddenly becoming visible after LASIK in patients who had no prior symptoms. This is one reason why preoperative screening for corneal dystrophies (and, in some countries, genetic testing for common TGFBI mutations) is part of the workup before refractive surgery. If you have a family history of corneal dystrophy and are considering LASIK, bring it up with your surgeon explicitly, because the standard exam may not catch early or subtle forms.
Fuchs dystrophy also matters in the refractive surgery context, but for a different reason. LASIK and especially procedures that touch the endothelium (like implantable contact lenses) carry some risk of worsening endothelial cell loss. For someone with early Fuchs whose cell counts are already borderline, that additional loss could push them toward symptomatic disease sooner than the dystrophy would have done on its own. Specular microscopy to count endothelial cells before refractive surgery is standard practice for exactly this reason.